AstraZeneca submitted a request earlier this week that Seroquel be approved for the treatment of schizophrenia in teenagers and for the treatment of acute manic episodes associated with bipolar I disorder in children and teens ages 10 to 17.
http://www.delawareonline.com/article/20081101/BUSINESS/811010309